Showing results (131-140 of 2,355) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|November 5, 2015
Antidepressant-Induced Sleep Bruxism: Prevalence, Incidence, and Related FactorsAli Ulvi Uca, Faruk Uğuz, Hasan Hüseyin Kozak, et al.Clinical Neuropharmacology|September 21, 2018
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label TrialTsuyoshi Miyaoka, Misako Kanayama, Rei Wake, et al.Clinical Neuropharmacology|May 3, 2019
Curcumin as Add-On to Antipsychotic Treatment in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyChanoch Miodownik, Vladimir Lerner, Natalie Kudkaeva, et al.Clinical Neuropharmacology|June 1, 1988
Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patientsA Weizman, M Mark, I Gil-Ad, et al.Clinical Neuropharmacology|January 1, 1986
Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeysU J Povlsen, U Noring, A L Laursen, et al.Clinical Neuropharmacology|October 15, 2021
Clozapine-Associated Pisa Syndrome: A Case Report of an Acute Reaction in a Bipolar PatientHenrique Castro Santos, João Oliveira, Ana Sofia Vieira, et al.Clinical Neuropharmacology|September 25, 2021
Low-Dose Lurasidone-Induced Polydipsia Complicated by Hyponatremia in a Patient With Bipolar DisorderSung-Tao Li, Yi-Wei YehClinical Neuropharmacology|January 1, 1987
Restless legs syndrome treatment with dopaminergic drugsS AkpinarClinical Neuropharmacology|February 23, 2022
Metronidazole-Induced Toxic Neuropathy With the "Boomerang" Sign: A Case ReportRitwik Ghosh, Subhankar Chatterjee, Mahua Jana Dubey, et al.Clinical Neuropharmacology|February 23, 2022
Effectiveness of Atomoxetine (Strattera) for the Treatment of Poststroke Aphasia Combined With Cognitive ImpairmentJong Mi Park, Soojin Choi, Yong Wook KimPageof 236